Given the disease-related changes in levels of relevant cytokines (for instance, leptin, adiponectin, reisitin, FGF21, Fetuin A, TNF-α, IL-6, MCP-1), these factors may serve as biomarkers for the early detection of metabolic disorders. The gene discussed is FGF21; the disease is metabolic disease.